Event to Address Healthcare Reform`s Impact on Biomedical Innovation
LA JOLLA, Calif.--(Business Wire)--
CHI-California Healthcare Institute today announced that due to high demand, the
registration for the 2009 California Healthcare Policy Forum to be held Nov. 5,
at the InterContinental Mark Hopkins San Francisco Hotel, from 11:30 a.m. to
6:00 p.m. has been extended to Thursday, Oct. 29. This annual statewide
conference brings together opinion leaders from the science, business and public
sectors to discuss opportunities and issues facing the biomedical community.
Featured speakers will include A. Eugene Washington, M.D., M.Sc., executive vice
chancellor and provost of University of California, San Francisco, David L.
Gollaher, Ph.D., president and chief executive officer, CHI; Sharon Levine,
M.D., associate executive medical director, The Permanente Medical Group,
Michael Goldberg, partner, Mohr Davidow Ventures, Alan M. Garber, M.D., Ph.D.,
director, center for health policy and center for primary care and outcomes
research, Stanford University, futurist Ian Morrison, Hans Bishop, president,
specialty medicine, Bayer HealthCare LLC, Robert B. Hance, president, Abbott
Vascular, Carl W. Hull, president and CEO, Gen-Probe Incorporated, Michael A.
Mussallem, chairman and CEO, Edwards Lifesciences, John C. Martin, Ph.D.,
chairman of the board and CEO, Gilead Sciences and Mark D. Smith, M.D., M.B.A.,
president and CEO, California HealthCare Foundation. Legislators, including
Assemblymembers Nathan Fletcher and Jose Solorio, will also speak at the event.
"This forum brings together industry leaders and policy makers for a
conversation about the relationship between public policy and biomedical
innovation," said Gollaher. "CHI believes that the implications of healthcare
reform for life sciences innovation are profound, and health reform proposals
must address cost-savings, improve quality and expand coverage without harming
future medical breakthroughs."
A topic of discussion at the forum will be the value of biomedical innovation as
the cost of medicines and new technologies present challenges to both public and
private payers. The biomedical community is opening a dialogue with state and
federal policy makers as well as payers and patients on reining in the cost of
medicine and medical technology while protecting innovation and encouraging
future investment in research and discovery.
The half-day forum will begin with a networking luncheon at 11:30 a.m., followed
by the "Healthcare Reform and Assessing the Value of Medical Innovation"
discussion at 12:30 p.m., which will include Gollaher, Goldberg, Garber, Levine,
and Washington, with Morrison moderating this conversation about competing
priorities within current healthcare reform proposals. Assemblymember Nathan
Fletcher will then address the attendees on California`s role in the healthcare
debate. Following his address, top biomedical industry executives in the state
of California, including Bishop, Hance and Hull, will discuss how proposed
healthcare policies will affect investment and product development. Next,
attendees will meet Assemblymember Jose Solorio during a salon interactive
session to discuss how industry leaders can effectively engage in the political
process. The forum will conclude with "Innovation at the Crossroads:
Cardiovascular Medicine and Infectious Disease," featuring Mussallem, Martin and
Smith, discussing the latest research from their companies and how federal
policy influences product decisions.
CHI has extended the registration deadline due to high demand. The rate for CHI
members is $295; non-members is $445 and academic and nonprofits is $95. Visit
www.chi.org/hcpf/default.aspx or call 858-551-6677 to register. Members of the
media may register at no cost. Visit the forum Web site for details.
About CHI
CHI represents more than 250 leading biotechnology, medical device, diagnostics,
and pharmaceutical companies, and public and private academic biomedical
research organizations. CHI`s mission is to advance responsible public policies
that foster medical innovation and promote scientific discovery. CHI`s Web site
is www.chi.org.
California Healthcare Institute
Nicole Beckstrand
858-551-6677
Beckstrand@chi.org
Copyright Business Wire 2009
